NIH funds research for combining genomic information, electronic records
This will help scientists improve their understanding of the genomic basis of illnesses and therefore offer patients better care that is tailored specifically to their needs.
The grants were from the National Human Genome Research Institute (NHGRI). They are the third phase of the new eMERGE program, the purpose of which is to further advance genomics research to clinical application. The scientists seek to identify potential medical effects on rare genomic variants, which are inherited differences within the person’s DNA code. The study currently involves approximately 100 clinically relevant genes. The activity levels of these genes can impact an individual’s health as well as the physician’s decisions for treatment.
“The newly funded projects are focused on discovering genes and gene variants with clinical implications by using the latest sequencing technologies to examine rare and common variants suspected to relate to disease risk and treatment effects,” Dr. Rongling Li, Ph.D., program director for eMERGE in the Division of Genomic Medicine at NHGRI, a part of NIH, said. “The other important component of these grants is implementing what researchers learn about these gene variants into medical settings to improve patient care.”